![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of Pre-Existing Levels of Y448H HCV NS5B Polymerase Mutant Using Viral Kinetics Monitored by Allele-Specific PCR in HCV Patients and Replicon Cells Treated with the HCV Non-Nucleoside Inhibitor Tegobuvir
|
|
|
Reported by Jules Levin AASLD Nov 5-8 2011 SF
KS Ku, D Goodman, P Pang, MD Miller, H Mo, ES Svarovskaia
Gilead Sciences, Foster City, CA United States
![AASLD1.gif](../images/111411/111411-9/AASLD1.gif)
![AASLD2.gif](../images/111411/111411-9/AASLD2.gif)
![AASLD3.gif](../images/111411/111411-9/AASLD3.gif)
![AASLD4.gif](../images/111411/111411-9/AASLD4.gif)
![AASLD5.gif](../images/111411/111411-9/AASLD5.gif)
![AASLD6.gif](../images/111411/111411-9/AASLD6.gif)
![AASLD7.gif](../images/111411/111411-9/AASLD7.gif)
![AASLD8.gif](../images/111411/111411-9/AASLD8.gif)
![AASLD9.gif](../images/111411/111411-9/AASLD9.gif)
![AASLD10.gif](../images/111411/111411-9/AASLD10.gif)
![AASLD11.gif](../images/111411/111411-9/AASLD11.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|